PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 1722113

Esophageal endoprosthesis therapy.

K Wright
View original source ↗Export metadata ↓

Abstract

Currently various methods for the treatment of obstructing esophageal lesions are used in the endoscopy setting. The placement of an endoscopic esophageal endoprosthesis (stent) offers a palliative form of therapy for esophageal cancer designed to enhance the patient's quality of life. The gastroenterology nurse or associate must be familiar with the various types of prostheses available, methods of insertion and patient care needs related to esophageal stent placement in order to provide optimal patient care. This article offers a review of esophageal endoprosthesis therapy. The various types of endoprostheses utilized in the United States, insertion techniques, advantages and disadvantages of stent placement and implications for patient care will be discussed.

Explore related subjects

Esophageal NeoplasmsEsophageal StenosisEsophagoscopyHumansPalliative CareProsthesis DesignStentsJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

K Wright. 1991. Esophageal endoprosthesis therapy.. https://doi.org/10.1097/00001610-199112000-00004

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

[Unexpected tumour of the distal esophagus].

We report a patient with unexpected intraoperative diagnosis of a big leiomyoma of the distal esophagus found during laparoscopic repair of a typ III hiatal hernia complicated by Cameron ulcer and chronic anaemia. Laparoscopic transhiatal enucleation of the tumour was performed with closure of the myotomy, Nissen fundoplication, and crural repair. Briefly, the literature of leiomyoma of the esophagus is reviewed with special regard to different therapeutic strategies.

Esophageal Neoplasms↗
PubMed2007

[MSCT for staging and response evaluation of esophageal cancer].

Squamous cell carcinomas and adenocarcinomas account for the majority of cases of esophageal cancer. Esophageal cancer often is diagnosed in advanced stages as clinical symptoms are lacking in early stages. The major aims of imaging in esophageal cancer are to determine local tumor extension (T and N staging), to rule out systemic disease (M staging), and to assess response to neoadjuvant therapy (response evaluation). CT is still inferior to endoscopic ultrasound in differentiating T stages and detecting regional lymph node metastases. However, it plays a central role in determining infiltration into adjacent organs (T4 stage) and in ruling out distant metastases. Multislice-CT (MSCT) offers the possibility of reconstructions, which often help to assess the relationship between tumor and anatomic landmarks like the tracheobronchial tree or the diaphragm. First results of CT volumetry for response evaluation are promising; however, PET and PET/CT with the glucose analogue FDG are the standard methods to evaluate response to neoadjuvant therapy.

Esophageal Neoplasms↗
PubMed2007

[Staging of esophageal cancer using ultrasound].

The early diagnosis of esophageal cancer is crucial for the prognosis of the disease. In contrast to cancer of the upper aerodigestive tract, the mucosa of the esophagus is not visible without the appropriate equipment. In addition to endoscopy, imaging of the esophagus is crucial for early detection of the esophageal cancer. Ultrasound of the esophagus can be performed easily and--in contrast to other imaging techniques--without side effects. Different modes of ultrasound can be performed. First, transcutaneous ultrasound allows one to detect tumors of the upper esophagus and its passage into the hypopharynx. Second, endosonography allows one to detect pathologies of the other esophageal regions including the passage into the stomach. The present review discusses the impact of both techniques against the background of the international literature.

Esophageal Neoplasms↗